Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Asset Utilization Ratio (2020 - 2025)

Ovid Therapeutics (OVID) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.09 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio rose 2007.81% year-over-year to 0.09, compared with a TTM value of 0.09 through Sep 2025, up 2007.81%, and an annual FY2024 reading of 0.0, up 82.96% over the prior year.
  • Asset Utilization Ratio was 0.09 for Q3 2025 at Ovid Therapeutics, down from 2.89 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 3.41 in Q3 2023 and bottomed at 0.0 in Q2 2024.
  • Average Asset Utilization Ratio over 5 years is 1.2, with a median of 1.04 recorded in 2021.
  • The sharpest move saw Asset Utilization Ratio plummeted 99.89% in 2024, then skyrocketed 84691.94% in 2025.
  • Year by year, Asset Utilization Ratio stood at 1.04 in 2021, then skyrocketed by 34.44% to 1.4 in 2022, then increased by 18.71% to 1.66 in 2023, then tumbled by 99.65% to 0.01 in 2024, then skyrocketed by 1510.47% to 0.09 in 2025.
  • Business Quant data shows Asset Utilization Ratio for OVID at 0.09 in Q3 2025, 2.89 in Q2 2025, and 2.58 in Q1 2025.